Nikolsky's sign
| Nikolsky's sign | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin blistering, epidermal detachment |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | Autoimmune disease, bacterial infection, toxic epidermal necrolysis |
| Risks | N/A |
| Diagnosis | Clinical examination |
| Differential diagnosis | Pemphigus vulgaris, Staphylococcal scalded skin syndrome, Stevens-Johnson syndrome |
| Prevention | N/A |
| Treatment | Depends on underlying cause |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Nikolsky's sign is a clinical dermatological sign that is indicative of skin blistering disorders, particularly those involving the epidermal layer. It is named after Pyotr Nikolsky, a Russian physician who first described it in 1896. The sign is positive when slight rubbing of the skin results in exfoliation of the outermost layer, revealing a moist, red area beneath. This is due to a loss of adhesion between skin cells, known as acantholysis.
Etiology[edit]
Nikolsky's sign is most commonly associated with pemphigus vulgaris, a rare autoimmune disorder characterized by the production of antibodies against desmoglein, a protein that facilitates cell-to-cell adhesion within the skin. Other conditions that may exhibit a positive Nikolsky's sign include Stevens-Johnson syndrome, toxic epidermal necrolysis, and staphylococcal scalded skin syndrome (SSSS). These conditions lead to varying degrees of skin and mucous membrane detachment and blistering.
Pathophysiology[edit]
The pathophysiology of Nikolsky's sign involves the disruption of desmosomes, which are structures responsible for cell-to-cell adhesion in the epidermis. In conditions like pemphigus vulgaris, autoantibodies target proteins within desmosomes, particularly desmoglein 1 and 3, leading to a loss of cell adhesion. This results in the epidermal layers easily separating upon mechanical stress, manifesting as the Nikolsky's sign.
Clinical Presentation[edit]
A positive Nikolsky's sign is elicited by applying lateral pressure to the skin, which leads to the top layer of the skin shearing off. This test is particularly performed on the perilesional skin, or skin adjacent to blisters or erosions. The presence of Nikolsky's sign indicates a high likelihood of a blistering skin disorder but is not specific to any single disease.
Diagnosis[edit]
The presence of Nikolsky's sign is an important clinical finding that prompts further diagnostic evaluation. Diagnosis of the underlying condition typically involves a combination of clinical examination, histopathology (skin biopsy), and direct immunofluorescence to identify the specific autoantibodies involved. The exact nature of the skin condition is determined based on the clinical presentation, history, and laboratory findings.
Management[edit]
Management of conditions associated with Nikolsky's sign involves addressing the underlying cause. In autoimmune conditions like pemphigus vulgaris, treatment may include systemic corticosteroids, immunosuppressants, and biologic therapies aimed at reducing antibody production. Supportive care, including wound care for blistered and eroded areas, is also crucial. The management strategy is tailored to the severity of the disease and the specific diagnosis.
Prognosis[edit]
The prognosis for patients with a positive Nikolsky's sign varies depending on the underlying condition and its response to treatment. With appropriate management, many patients can achieve disease remission. However, conditions like toxic epidermal necrolysis have a high mortality rate, emphasizing the importance of early recognition and treatment.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian